Free Trial

PureTech Health (LON:PRTC) Stock Price Up 1.1% - Should You Buy?

PureTech Health logo with Medical background

PureTech Health plc (LON:PRTC - Get Free Report)'s stock price traded up 1.1% during trading on Wednesday . The stock traded as high as GBX 168.80 ($2.15) and last traded at GBX 168.40 ($2.15). 361,723 shares were traded during trading, a decline of 36% from the average session volume of 561,587 shares. The stock had previously closed at GBX 166.60 ($2.13).

PureTech Health Trading Down 1.9 %

The company has a current ratio of 3.68, a quick ratio of 2.51 and a debt-to-equity ratio of 47.27. The firm's 50-day moving average is GBX 158.35 and its 200 day moving average is GBX 174.28. The firm has a market capitalization of £395.52 million, a price-to-earnings ratio of -718.26 and a beta of 1.02.

PureTech Health Company Profile

(Get Free Report)

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.

Further Reading

→ The #1 Coin for November 2024 (From Crypto 101 Media) (Ad)

Should you invest $1,000 in PureTech Health right now?

Before you consider PureTech Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PureTech Health wasn't on the list.

While PureTech Health currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines